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Abstract
Background: Older adults with multiple chronic diseases commonly require complex medication regimes. When combined
with frailty, cognitive impairment, and changing pharmacological prescriptions, older adults’ polymedication regimes increase
the risk of medication-related problems (MRPs) and hospitalization. Effective, well-organized medication management could
avoid MRPs and their clinical outcomes.
Objective: Identify medication management models and analyze their impact on managing and preventing MRPs for
polymedicated, home-dwelling older adults.
Methods: We will conduct a systematic review of published articles in relevant professional scientific journals from inception
until March 31, 2019, in the following electronic databases,: Embase; Medline OvidSP; PubMed (NOT Medline[sb]); Cumulative
Index to Nursing and Allied Health Literature (CINAHL) EBSCO; PsycINFO OvidSP; Cochrane Library, Wiley; and Web of
Science. We will also hand search the bibliographies of all the relevant articles found and search for unpublished studies. We
will consider publications in English, French, German, Spanish, Italian, and Portuguese. Retrieved articles will be screened for
eligibility. Statistical analyses will be conducted following the recommendations of the Cochrane Handbook for Systematic
Reviews of Interventions, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), and Meta-analysis
Of Observational Studies in Epidemiology (MOOSE) statements. Data will be analyzed using SPSS Statistics for Windows,
version 25.0 (IBM Corp), and Review Manager, version 5.5 (The Nordic Cochrane Centre, The Cochrane Collaboration).
Results: A preliminary search in Embase delivered 3272 references. This preliminary search allows us to complete our research
strategy with equation development and to search the other databases. Relevant articles identified will allow for searching the
reference lists for unpublished studies. The inclusion and exclusion criteria will be rigorously respected in the study selection.
The entire study is expected to be completed by January 2020.
Conclusions: This review will provide an exhaustive view of medication management models that could be effective for
polymedicated, home-dwelling older adults and will allow us to analyze their impact on managing and preventing MRPs.
Trial Registration: PROSPERO CRD42018117287; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=117287
(Archived by WebCite at http://www.webcitation.org/77fCfbCjT)
International Registered Report Identifier (IRRID): DERR1-10.2196/13582
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Introduction
Health care systems across Europe are being challenged by an
ageing population [1]. International statistics demonstrate that
home-dwelling older adults consume huge amounts of prescribed
and over-the-counter medication [2,3]. The risks of medication
prescription and deprescription have been debated since the
dissemination of systematic and umbrella reviews pointing out
the inconsistency of some pharmacological treatments for older
adults [4,5]. However, a substantial proportion of older adults
have multiple chronic diseases requiring numerous treatment
components and complex medication regimes [6]. Increasingly
complex medication regimes, combined with frailty, reduced
cognitive function, and changing pharmacokinetics and
pharmacodynamics, increase the risk of adverse drug events
and other medication-related problems (MRPs) in this population
[7]. An MRP is “an event or circumstance involving medication
therapy that actually or potentially interferes with desired health
outcomes” [8]. MRPs include inappropriate prescribing (ie,
wrong drug, dose, dosage frequency, or dosage form), drug
interactions, adverse drug reactions, incorrect administration,
the need for monitoring, and nonadherence to medication
therapy [9]. MRPs occur frequently among polymedicated,
home-dwelling older adults and are associated with increased
risks of hospitalization, morbidity, and mortality [10-12].
Avoidable adverse drug events are the serious consequences of
inappropriate drug prescribing [13]. For instance, adverse drug
events alone contribute to 30%-40% of acute hospital admissions
among older adults, although many are preventable [14]. The
World Health Organization has estimated that 50% of patients
suffering from chronic diseases either do not take their
medication or fail to follow instructions for their medical
prescription [15]. Medication management among
polymedicated, home-dwelling older adults is a serious problem
because of the increased burden of symptoms and disease,
leading to the use of more medicines and a greater chance of
suboptimal management. Estimates of medication nonadherence
vary from 40% to 75% [16].
The misuse of categories of drugs such as sleeping pills,
analgesics, tranquilizers, appetite suppressants, and stimulants
is common [17]. Problems associated with low or zero
therapeutic adherence are even more evident during the sensitive
period following discharge home from hospital [18]. Suboptimal
medication management may lead to a deterioration in the
patient’s clinical condition, avoidable short-term hospitalizations
or readmissions, physical and cognitive decline, exacerbated
chronic medical conditions, and, consequently, increased health
care use and costs [18-20]. The indirect impacts of the adverse
effects of drug nonadherence, such as falls, dehydration, or
delirium, may also lead to hospitalizations [21]. Older adults
often undergo changes to dosage and prescribed medication
during hospitalization [22] and during the first few months after
hospital discharge due to comorbidities and the need for disease
stabilization [19]. Such changes tend to decrease optimal
medication management [23]. Older adults may also go back
to taking medications that were discontinued during
hospitalization, fail to begin a new treatment initiated during
hospitalization, or take incorrect dosages [18]; they are
particularly at risk of nonadherence in the first days or weeks
after hospital discharge [18]. Home-dwelling older adults taking
five or more drugs are considered to be more susceptible to the
consequences of polypharmacy, such as adverse drug reactions,
drug-drug interactions, nonadherence, or drug-food interactions.
Monitoring, assessing, and reacting accordingly are requisite
skills for optimal medication management in cases involving
inappropriate polymedication or excessive polymedication [24].
Optimal medication management should thus be an integral part
of older adults’ daily lives and is an essential condition for
successfully maintaining them at home [25,26]. Moreover,
taking into account the high prevalence of multiple chronic
conditions in this population, optimal medication management
often becomes a determinant of an older adult’s state of health
and quality of life at home [27]. Medication management in
polymedicated, home-dwelling older people has been described
as the “single most important health care intervention in the
industrialized world” [28]. This brings us to our search for the
best practice models that optimize safety, the continuity of
medication intake, and overall medication management among
home-dwelling older adults [6]. With the overall aim of
developing effective strategies to prevent MRPs and avoiding
medication-related hospitalizations and rehospitalizations, many
researchers and clinicians involved in primary care have tried
to generate either general or specific structured, systematic,
medication management models for polymedicated
home-dwelling older adults.
One recent example of a structured action to prevent MRPs is
the Medication Management Model. This is based on risk
management and provides home-dwelling patients with
medication review services comparable to those that benefit
hospital and nursing home patients [29]. A second example
concerns the Coordinated Medication Management Model,
which involves home care nurses, nurses, physicians, and
community pharmacists in medication processes for
home-dwelling older adults, supported by home health care
services [30]. Medication management models are
interprofessional collaboration processes between patients, their
informal caregivers, pharmacists, and nurses, based on
evidence-based guidelines and bringing, if appropriate, identified
problems to a physician’s attention [26]. To the best of our
knowledge, there have been no systematic reviews summarizing
the medication management models developed in community
health care and their impact on MRPs among polymedicated,
home-dwelling older adults.
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Methods
Overview
This protocol has been registered in the International Prospective
Register of Systematic Reviews (PROSPERO) (protocol number
CRD42018117287). The systematic review will be conducted
following the recommendations of the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses for Protocols
(PRISMA-P) and its checklist for reporting harms [31,32], the
reporting proposals of the Meta-analysis Of Observational
Studies in Epidemiology (MOOSE) [33], and the methods
outlined in the Cochrane Handbook for Systematic Reviews of
Interventions [34].
Purpose and Research Question
This systematic review’s purpose is to identify, examine, and
summarize the models developed in community health care
systems to optimize medication management for polymedicated,
home-dwelling older adults. The following research question
will guide this review: Which community health care models
for optimizing medication management for polymedicated,
home-dwelling older adults have been reported in interventional
and observational studies?
Inclusion and Exclusion Criteria
Types of Studies
This review will include randomized controlled trials, cluster
randomized controlled trials, and nonrandomized studies.
Nonrandomized studies will include quantitative studies
examining the effects of medication management models that
do not use randomization to allocate patients to comparison
groups [34]. We will include retrospective and prospective
epidemiological studies, cohort studies, case-control studies,
controlled before-and-after studies, interrupted-time-series
studies, and controlled trials with inappropriate randomization
(ie, quasi-experimental studies) [35,36]. We will search for
papers in French, German, English, Spanish, Italian, and
Portuguese.
Types of Participants
This review will consider studies involving polymedicated,
home-dwelling older adults with multiple chronic conditions
and a minimum mean age of 65 years, as well as studies with
participants aged 55 years or older. In order to properly include
heterogeneity and complexity, we will consider multiple chronic
conditions: the co-occurrence of at least two diseases in the
same individual, cumulative indices considering both the number
and severity of concurrent diseases, and the simultaneous
presence of not only diseases but also symptoms and physical
and cognitive dysfunctions.
Types of Models
We will examine all types of medication management models,
including strategies, interventions, and clinical pathways aimed
at optimizing the effects of medication management for
polymedicated, home-dwelling older adults with multiple
chronic conditions. Given their impact in reducing medication
errors and enhancing interprofessional collaboration and patient
safety, electronic medication management systems (EMMS)
will be included in this study [37,38].
Where possible, these types of medication management models
will be compared with usual care and will include strategies
documented in models, interventions, and clinical pathways
delivered by a primary health care provider alone or in
collaboration with other allied health care professionals at home.
Based on the Effective Practice and Organization of Care
(EPOC) taxonomy of health system interventions [39], we will
consider medication management models, interventions, and
clinical pathways targeting the health care professional level
and the patient level, as discussed below, but we will exclude
those targeting health care organizations:
1. Optimized medication management at the health care
professional level:
a. Educational programs aimed at optimizing medication
management.
b. Distribution of materials aimed at optimizing
medication management.
c. Feedback to peers and other involved health care
professionals on the effects and impact of medication
management (ie, medication review from medical
records).
d. Monitoring medication management models, including
interventions and clinical pathways (ie, assessment,
adjustment or change of medication, and medication
deprescription).
e. Verbal recommendations to polymedicated,
home-dwelling older adults by the health care providers
involved to optimize medication management (eg,
pharmacists and physicians).
f. The organized activities of teams for medication
conciliation, prescription, and deprescription.
g. EMMS covering prescription, administration, pharmacy
review, barcode medication administration, and
anything that encompasses medication management
processes for polymedicated, home-dwelling older
adults with multiple chronic conditions [40].
h. Evaluations of the involvement of different health care
professionals in the optimization of medication
management.
2. Optimized medication management at the level of
polymedicated, home-dwelling older adults:
a. Organized interventions aimed at optimizing medication
management for polymedicated, home-dwelling older
adults (ie, single- or multi-professional interactions
conducted by nurses, pharmacists, or physicians, such
as counselling on medication and medication
compliance or patient education sessions).
b. Patient reminder systems aimed at optimizing
medication management (ie, single- or
multi-professional interventions conducted by nurses,
pharmacists, or physicians, such as telephone contact
and discharge planning; medication adherence aids,
such as electronic monitors or pill dispensers; and
meetings with the multi-professional health care team
in the patient’s home).
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Types of Outcome Measures
This review’s primary outcome measures will be:
1. The identification of models including interventions, clinical
pathways, and EMMS aimed at optimizing medication
management for polymedicated, home-dwelling older adults
in primary health care.
2. The description of the components of the models,
interventions, and clinical pathways and the identification
of the stakeholders involved (ie, professional and
nonprofessional caregivers).
3. The description of the impact of medication management
models, interventions, and clinical pathways versus usual
care on:
a. Rates of hospitalization for MRPs.
b. Rates of emergency department visits for MRPs.
Primary outcomes will be measured by different methods based
on dichotomous (ie, yes or no), ordinal, or continuous rates and
scores (eg, hospitalization or rehospitalization, frailty severity
or progress, emergency department visits for MRP [10], and
misuse of medication [41]).
This review’s secondary outcome measures will be descriptions
of the associations between sociodemographic characteristics,
health data, and MRPs (ie, nominal, ordinal, or interval level).
Information Sources and Search Strategy
We will search the following databases, without restriction on
the publication date: Embase (from 1947); Medline OvidSP
(from 1946); a subset (sb) of PubMed (NOT Medline[sb]) (from
1996); Cumulative Index to Nursing and Allied Health Literature
(CINAHL) EBSCO (from 1937); PsycINFO OvidSP (from
1887); Cochrane Library, Wiley (from 1992); and Web of
Science (from 1900). Furthermore, we will search in the
reference lists of relevant articles identified and for unpublished
studies.
The search syntax will use Medical Subject Headings (MeSH)
and text terms with Boolean operators. The syntax will consist
of the search themes intersected by the Boolean terms “AND”
and “OR.” MeSH terms and free keywords will include the
following:
1. Terms for “Medication management,” “Drug therapy
management,” “Therapeutic medication management,” and
“Optimizing medication treatment.”
2. Terms for “Community-dwelling older adults,”
“Home-dwelling older adults,” “Elderly,” “Aged,”
“Home-care patients,” “Older adults,” and “Very old
adults.”
3. Terms for “Home-dwelling,” “Living in place,”
“Homebound,” “Primary care,” “Community health
services,” “Community hospital,” “Ambulatory care,”
“Outpatient clinics,” “Hospital,” “Ambulatory care
facilities,” “Day care,” “Primary health care,” “Community
health centers,” “Health services for the aged,”
“Community,” “Domicile,” “Home or home-care or
home-based,” “Outpatient,” “Day patient,” “Community
care,” “Home-care services,” “General practice,” and
“Urban population.”
4. Terms for “Multiple chronic conditions,” “Frailty,”
“Vulnerability,” “Multimorbidity,” “Multimorbid,” “Muscle
weakness,” “Fatigue,” “Slow motor performance,” “Low
physical activity,” and “Unintentional weight loss.”
5. Terms related to “Drug-related problems,”
“Medication-related problems,” “Misuse of medication,”
“Medication abuse,” “Inappropriate polypharmacy,”
“Polypharmacy,” “Excessive polypharmacy,” and
“Polymedication.”
6. Terms for models, interventions, and clinical pathways:
“Care model,” “Care map,” “Multidisciplinary care,”
“Evidence-based care,” “Guideline,” “Patient care plans,”
“Clinical paths,” “Clinical pathways,” “Critical paths,” and
“Interventions.”
7. Terms related to “Medication management model,”
“Medication optimization,” and “Reconciliation.”
8. Terms for “Computerized provider order entry,” “Electronic
prescribing,” “Computer-assisted diagnosis,”
“Computer-assisted therapy,” and “Medical device.”
Study Selection
Two reviewers (FP and PR) will independently screen the titles
and abstracts identified in the searches to assess which studies
meet the inclusion criteria. Disagreements will be resolved
through discussion or, if needed, a consensus will be reached
after discussion with coauthors (MMM and HV). The reviewers
will then independently assess the full-text articles to ensure
that they meet the inclusion criteria. Disagreements will be
discussed and resolved with coauthors (MMM and HV). A
flowchart of the trial selection process has been drawn in
accordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement [42] (see
Figure 1).
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Figure 1. Blank flow diagram based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [42].
Data Extraction
Data will be extracted independently by two authors (FP and
PR) using a specially designed, standardized data extraction
form. Discrepancies will be resolved through discussion and
consultation with coauthors (MMM and HV).
The following information will be extracted from each study
included in the review: (1) study authors, year of publication,
and country where the study was conducted; (2) study
characteristics, including setting, design, duration of follow-up,
and sample size; (3) participants’ characteristics, including age,
sex, social status, marital status, educational status, level of
autonomy, history of hospitalization and rehospitalization for
MRPs, and emergency department visits for MRPs; medication
management model; interventions; and clinical pathways; (4)
multiple chronic conditions measured using indices (ie, the
Charlson Comorbidity Index and the Cumulative Illness Rating
Scale-Geriatric); and (5) types of outcome measures.
Assessment of the Risks of Bias in Included Studies
Two reviewers (FP and PR) will independently assess the risks
of bias in all the randomized and nonrandomized studies for
interventions (NRSI) included, using the validated Cochrane
Risk of Bias Tool, version 2.0 (The Cochrane Collaboration)
[43]. This tool is based on five domains: (1) bias arising from
the randomization process, (2) bias due to deviations from
intended interventions, (3) bias due to missing outcome data,
(4) bias in outcome measurement, and (5) bias in the selection
of the results reported. Each of these five domains will be rated
as (1) low risk of bias, (2) some concerns about bias, or (3) high
risk of bias. Declaring that a study has a particular level of risk
of bias in any individual domain will mean that the study as a
whole has a risk of bias. Disagreements will be resolved through
discussion and consultation with coauthors (MMM and HV).
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We will also use the validated Risk of Bias In Nonrandomized
Studies of Interventions (ROBINS-I) tool for assessing the risk
of bias in NRSI [44]. This tool covers two dimensions and seven
domains through which bias might be introduced into NRSI:
(1) preintervention and during the intervention (ie, bias due to
confounding, selection of study participants, or classification
of the intervention) and (2) postintervention (ie, bias due to
deviations from intended interventions, missing data,
measurement of outcomes, and selection of the reported result)
[44]. Any disagreements in quality assessments will be resolved
through discussion.
Statistical Analyses
Statistical analyses will be conducted by FP and PR following
the recommendations of the Cochrane Handbook for Systematic
Reviews of Interventions [34] and the PRISMA-P and MOOSE
statements [31,33]. For dichotomous outcomes, average
intervention effects (ie, pooled effect and meta-analysis) will
be calculated as relative risks with 95% CIs using a
random-effects model [45]. For continuous data, a
random-effects model will be used to calculate weighted-mean
differences with 95% CIs. If required, we will calculate standard
deviations from the standard errors or 95% CIs presented in the
articles. Heterogeneity will be quantified using the I2 and
chi-square tests. Funnel plots will be drawn and Egger’s test
will be computed to explore the possibility of publication bias
[46].
Reasons for heterogeneity in effect estimates will be sought in
meta-analyses [47,48]. To explore the possible determinants of
heterogeneity, we will conduct subgroup analyses according to
selected study characteristics (eg, participants’ ages; country
where the study was conducted; types of professions; and types
of models, interventions, and clinical pathways). Furthermore,
sensitivity analyses will be conducted by (1) excluding relatively
small studies (ie, fewer than 20 participants per randomization
group) and (2) restricting analyses to good-quality studies. Data
will be analyzed using SPSS Statistics for Windows, version
25.0 (IBM Corp), and Review Manager, version 5.5 (The Nordic
Cochrane Centre, The Cochrane Collaboration).
Results
To date, searches in Embase have been performed, delivering
3272 references. As of publication of this protocol, we are
developing the search equations in the remaining databases to
then initiate the process of study selection, rigorously applying
the inclusion and exclusion criteria. The final results are
expected in January 2020.
Discussion
Principal Considerations
To the best of our knowledge, this systematic review will be
the first to synthesize evidence about medication management
models, including their interventions, clinical pathways, and
EMMS, as well as their impacts on MRPs among polymedicated,
home-dwelling older adults.
Since MRPs are associated with an increased risk of hospital
readmissions, morbidity, and mortality and are significant issues
for the health care system, it is very important to develop
intervention strategies to resolve or prevent them. The
suboptimal medication management causing MRPs involving
the hospitalization of polymedicated, home-dwelling older adults
is underrecognized by community health care providers,
especially by frontline community health care nurses. Therefore,
an important task for community health care providers is to
identify, resolve, and prevent the occurrence of MRPs in this
rapidly growing population of polymedicated, home-dwelling
older adults.
The results of this systematic review may guide future research
in this avenue. The results may also contribute to the
development of comprehensive and implementable
recommendations for primary health care practitioners and
policy makers concerning medication management among
polymedicated, home-dwelling older adults.
Strengths and Limitations
This systematic review protocol’s strengths are as follows: (1)
clear definitions of the major concepts of medication
management models, multiple chronic conditions, clinical
pathways, and interventions; (2) the use of an appropriate search
strategy designed in collaboration with a health librarian
experienced in conducting such reviews; and (3) the inclusion
criteria, which impose few restrictions on the study’s language,
age, or geographic location. Nevertheless, there are several
limitations that should be noted. The authors’ personal
judgements may introduce bias into the assessment. Nonetheless,
this risk will be reduced by using two reviewers to select and
assess the eligibility of studies independently. Furthermore, it
is possible that some eligible studies may not be covered by our
research strategy. We will seek to minimize this limitation
through the contribution of an experienced health librarian.
Finally, the expected heterogeneity of studies about medication
management models for polymedicated, home-dwelling older
adults with multiple chronic conditions may influence our ability
to state comprehensive and implementable recommendations
from the literature.
Conclusions
This systematic review will synthesize the available evidence
about medication management models among polymedicated,
home-dwelling older adults and their impact on MRPs. We
expect our findings to provide meaningful evidence toward the
optimization of health care models, programs, and services for
polymedicated, home-dwelling older adults with multiple
chronic conditions.
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